about
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens.Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.Biology and therapeutic targeting of tumour-associated macrophagesChemotherapy elicits pro-metastatic extracellular vesicles in breast cancer modelsPerivascular macrophages in health and diseaseEngineering dendritic cell vaccines to improve cancer immunotherapyLymphoma Chemotherapy: Hungry Macrophages Strike the Final Blow
P50
Q38707904-A2B1632E-5789-4630-8124-9602261CA8CFQ48198779-0E234E39-12A3-4418-B299-1CCDAD6131A5Q50045161-CFF5AB7F-4C8E-44BA-9723-0D9588491874Q52593234-C38E1637-1511-4896-AAED-F69DCBD30C7EQ89839557-B108049F-F7F5-4742-BB2D-2235A03CEDD1Q90833182-91708013-56C9-43F7-93E6-FF897E0C4D42Q91048642-E508946F-2C3C-4D22-907F-26C94C05884EQ91496410-E2A56DB5-B171-4C4C-8F1E-886C2A4D77E1Q91525967-CFEA21BB-4D07-4BC2-B72B-FFFE73FA1E1A
P50
description
researcher
@en
wetenschapper
@nl
name
Michele De Palma
@en
Michele De Palma
@nl
type
label
Michele De Palma
@en
Michele De Palma
@nl
prefLabel
Michele De Palma
@en
Michele De Palma
@nl
P31
P496
0000-0001-9128-5459